These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9732832)

  • 1. [Expression of CD44 variant v6 in breast carcinoma and its relationship with other parameters of tumor biology].
    Aceituno E; Turrión F; San Román JM; Sarasa JL; Ortiz F; García R
    Med Clin (Barc); 1998 Jul; 111(5):168-71. PubMed ID: 9732832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic factors of breast cancer].
    Tang P; Wei B; Yang WJ; Liu YS; Bu H
    Zhonghua Bing Li Xue Za Zhi; 2011 Feb; 40(2):73-6. PubMed ID: 21426799
    [No Abstract]   [Full Text] [Related]  

  • 3. Expression of the CD44 variant isoforms 6 and 4/5 in breast cancer. Correlation with established prognostic parameters.
    Regidor PA; Callies R; Regidor M; Günthert U; Zöller M; Schindler AE
    Arch Gynecol Obstet; 1996; 258(3):125-35. PubMed ID: 8781700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry vs. Ki67 labelling index in breast cancer: a prospective evaluation of 181 cases.
    Martínez-Arribas F; Núñez MJ; Piqueras V; Lucas AR; Sánchez J; Tejerina A; Schneider J
    Anticancer Res; 2002; 22(1A):295-8. PubMed ID: 12017306
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of immunohistochemistry and RT-PCR for detection of CD44v-expression, a new prognostic factor in human breast cancer.
    Dall P; Heider KH; Sinn HP; Skroch-Angel P; Adolf G; Kaufmann M; Herrlich P; Ponta H
    Int J Cancer; 1995 Feb; 60(4):471-7. PubMed ID: 7530237
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression of adhesive molecule CD44v6 and p53 gene in breast cancer tissues and its relation with DNA ploidy].
    Zuo WS; Wei L; Wang XW; Wang YS; Yu ZY
    Ai Zheng; 2004 Nov; 23(11 Suppl):1418-22. PubMed ID: 15566648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of flow and image cytometry for DNA content analysis of fresh and formalin-fixed, paraffin-embedded tissue in breast carcinoma.
    Chen TL; Luo I; Mikhail N; Rasková J; Raska K
    Cytometry; 1995 Sep; 22(3):181-9. PubMed ID: 8556949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive value of CD44 and CD24 for prognosis and chemotherapy response in invasive breast ductal carcinoma.
    Chen Y; Song J; Jiang Y; Yu C; Ma Z
    Int J Clin Exp Pathol; 2015; 8(9):11287-95. PubMed ID: 26617852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 isoforms with exon v6 and metastasis of primary N0M0 breast carcinomas.
    Guriec N; Gairard B; Marcellin L; Wilk A; Caldéroli H; Renaud R; Bergerat JP; Oberling F
    Breast Cancer Res Treat; 1997 Jul; 44(3):261-8. PubMed ID: 9266106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical localization of metallothionein in human breast cancer in comparison with cathepsin D, stromelysin-1, CD44, extracellular matrix components, P53, Rb, C-erbB-2, EGFR, steroid receptor content and proliferation.
    Ioachim E; Kamina S; Demou A; Kontostolis M; Lolis D; Agnantis NJ
    Anticancer Res; 1999; 19(3A):2133-9. PubMed ID: 10470161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of the antigen recognized by the monoclonal antibody GB24 on human breast carcinomas: a preventive mechanism of malignant tumor cells against complement attack?
    Hofman P; Hsi BL; Manie S; Fenichel P; Thyss A; Rossi B
    Breast Cancer Res Treat; 1994; 32(2):213-9. PubMed ID: 7532466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical role of HER2 gene amplification and chromosome 17: a study on 154 IHC-equivocal cases of invasive breast carcinoma patients.
    Afzal M; Amir M; Hassan MJ; Hussain MS; Aziz MN; Murad S; Murtaza I; Anees M; Sultan A
    Tumour Biol; 2016 Jul; 37(7):8665-72. PubMed ID: 26738861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical analysis of medullary breast carcinoma autoantigens in different histological types of breast carcinomas.
    Kostianets O; Antoniuk S; Filonenko V; Kiyamova R
    Diagn Pathol; 2012 Nov; 7():161. PubMed ID: 23181716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and amplification of cyclin D1 in primary breast carcinomas: relationship with histopathological types and clinico-pathological parameters.
    Naidu R; Wahab NA; Yadav MM; Kutty MK
    Oncol Rep; 2002; 9(2):409-16. PubMed ID: 11836618
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterization of CD44
    Da Cruz Paula A; Leitão C; Marques O; Rosa AM; Santos AH; Rêma A; de Fátima Faria M; Rocha A; Costa JL; Lima M; Lopes C
    Virchows Arch; 2017 Mar; 470(3):311-322. PubMed ID: 28116522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitochondrial UCP4 and bcl-2 expression in imprints of breast carcinomas: relationship with DNA ploidy and classical prognostic factors.
    Gonidi M; Athanassiadou AM; Patsouris E; Tsipis A; Dimopoulos S; Kyriakidou V; Chelidonis G; Athanassiadou P
    Pathol Res Pract; 2011 Jun; 207(6):377-82. PubMed ID: 21621926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Her-2 amplification and p185 expression in invasive breast cancer cells in women].
    Titi S
    Ann Acad Med Stetin; 2006; 52(2):5-12. PubMed ID: 17633393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Her-2/neu, Ki-67 expression and ploidy in breast carcinoma].
    Lukashina MI; Glukhova EI; Zhukova LG; Ermilova VD; Bogatyrev VN; Baryshnikov AIu
    Arkh Patol; 2003; 65(5):25-9. PubMed ID: 14664144
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of HAb18G is associated with tumor progression and prognosis of breast carcinoma.
    Liu F; Cui L; Zhang Y; Chen L; Wang Y; Fan Y; Lei T; Gu F; Lang R; Pringle GA; Zhang X; Chen Z; Fu L
    Breast Cancer Res Treat; 2010 Dec; 124(3):677-88. PubMed ID: 20213083
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Macrophage infiltrate and prognosis in c-erbB-2-overexpressing breast carcinomas.
    Pupa SM; Bufalino R; Invernizzi AM; Andreola S; Rilke F; Lombardi L; Colnaghi MI; Ménard S
    J Clin Oncol; 1996 Jan; 14(1):85-94. PubMed ID: 8558226
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.